Adenuric (febuxostat) is a
potent, nonpurine, selective
inhibitor of xanthine oxidase
(XO) that prevents the normal
oxidation of purines to uric acid.
Adenuric is indicated in the
treatment of chronic symptomatic
hyperuricaemia in conditions
where urate deposition has
already occurred (gouty arthritis
and/or tophus formation) in adults
with gout. Adenuric is available as
an 80 mg tablet in packs of 28’s.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.